MedPath

A single dose intra-articular hyaluronic acid injection in patellofemoral osteoarthritis: a randomized, double-blinded trial

Phase 3
Completed
Conditions
Patellofemoral Arthritis
Patellofemoral arthritis
Chondromalacia patella
Anterior knee pain
Hyaluronic acid
Intra-articular injection
Registration Number
TCTR20210224001
Lead Sponsor
Queen Savang Vaddhana Memorial Hospital
Brief Summary

Hyaluronic acid was superior to saline in improving knee pain and function in the immediate pain improvement from day 1 post injection and lasted up to 2 weeks in Patellofemoral arthritis patients. However, no differences were observed in 1 to 6 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
70
Inclusion Criteria

1. Diagnosis of Patellofemoral osteoarthritis with anterior knee or retropatellar pain that is exacerbated by knee-bending activity including joint-loading activities, going up the stairs, or standing up from sitting position
2. Age 20-60 years
3. Pain score according to Visual Analogue Scale (VAS) more than equal to 3
4. a trial of conservative treatment for 3 months with no significant improvement
5. Radiological diagnosis of Iwano Classification grade 1-4

Exclusion Criteria

1. Osteoarthritis of tibiofemoral joint according to Kellegren and Lawrence Classification of at least grade 3
2. History of allergic reaction of any medication in this study
3. History of prior injury to the knee
4. Infection at the knee

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain 2, 4, 8, 24 week VAS score
Secondary Outcome Measures
NameTimeMethod
Functional score 2, 4, 8, 24 week WOMAC Score,Range of motion 2, 4, 8, 24 week Knee flexion and Extension in degrees,Adverse reaction 2, 4, 8, 24 week Clinical Observation of skin reaction and infection
© Copyright 2025. All Rights Reserved by MedPath